glp 1 agonist medullary thyroid cancer Can a Glucagon-like peptide-1 (GLP-1) receptor be prescribed to a patient with a history of non-medullary cancer? Implications of GLP-1 Receptor Agonist
Description
2024;17(2):p
Instead, he advised baseline retinal examinations in patients with diabetes before initiating therapy and closer monitoring for those with severe NPDR or proliferative DR during periods of rapid glycemic improvement (Figure 3)
This condition usually affects the vision in one eye and is not typically characterized by total blindness
Cancers (Basel) 6 , 926957 (2014)
Tirzepatide is the active ingredient in Zepbound (FDA-approved for chronic weight management) and Mounjaro (FDA-approved for type 2 diabetes)
